Costs of Home Mechanical Ventilation and Oxygen Therapy in Russia: Real-World Data
Speaker(s)
Krysanova V1, Krysanov I2, Ermakova V3, Makarova E4, Kurkin DV2
1Medical Institute of Continuing Education, BIOTECH University, Moscow, Russian Federation, 2A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, MOW, Russian Federation, 3Sechenov First Moscow State Medical University, Moscow, Russian Federation, 4A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Santiago de Compostela, C, Spain
Presentation Documents
OBJECTIVES: The aim of the study was to assess the socio-economic burden of managing patients with chronic diseases accompanied by chronic respiratory failure (CRF) and requiring long-term home mechanical ventilation (non-invasive or invasive) and/or oxygen therapy in Russia.
METHODS: The work consisted of two parts: an observational study of real-world clinical practice (2021-2022) and, based on the data obtained, economic model for a long-term home ventilation. The first part of the work included 65 patients (mean age 61 years, proportion of men 56.9%, n=37) with diseases accompanied by CRF (COPD, obesity hypoventilation syndrome, congenital kyphoscoliosis, consequences of spinal injury, amyotrophic lateral sclerosis, lymphangioleiomyomatosis, histiocytosis, idiopathic pulmonary fibrosis, post-COVID syndrome, etc.), receiving different types of home ventilation during 9 months. The total economic burden associated with the management of patients requiring long-term home ventilation and oxygen therapy was determined as the sum of all types of analyzed direct (medical and non-medical) and indirect costs, the data for the calculation were collected based on medical records and patients’ diaries.
RESULTS: The total costs for all included patients during 9 months amounted to €250,398.95 excluding the cost of necessary medical equipment and consumables. Direct medical expenses accounted for the largest share of costs (€176,373.99), direct non-medical costs amounted to €65 845,76., and indirect - €8,179.2. The weighted average costs per 1 patient with a chronic disease requiring long-term home mechanical ventilation and oxygen therapy amounted to €8,248.47 within 1 year, excluding the necessary medical equipment and consumables. Direct medical costs amount to €6,695.73, direct non-medical costs – €1,382.69, indirect - €170.05 (rate for June, 2023).
CONCLUSIONS: The analysis is the first experience in assessing the costs of long-term home mechanical ventilation and oxygen therapy in patients with various chronic diseases in real-world clinical practice, which demonstrates the high economic burden on the healthcare system, society and the patient.
Code
EE100
Topic
Economic Evaluation, Real World Data & Information Systems, Study Approaches
Topic Subcategory
Data Protection, Integrity, & Quality Assurance, Electronic Medical & Health Records, Trial-Based Economic Evaluation
Disease
Musculoskeletal Disorders (Arthritis, Bone Disorders, Osteoporosis, Other Musculoskeletal), Neurological Disorders, Respiratory-Related Disorders (Allergy, Asthma, Smoking, Other Respiratory)